European equities traded in the US as American depositary receipts were trending lower late Wednesday morning, declining 0.9% to 1,215.82 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by financial services companies Banco Bilbao Vizcaya Argentaria (BBVA) and Banco Santander (SAN), which rose 2.8% and 2% respectively, followed by software firm SAP (SAP), which was up 0.3%.
The decliners from continental Europe were led by biopharmaceutical companies Ascendis Pharma (ASND) and DBV Technologies (DBVT), which dropped 7.7% and 5.6% respectively. They were followed by biopharmaceutical companies Genfit (GNFT) and argenx (ARGX), which lost 4.8% and 4.4% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical company NuCana (NCNA) and mining company BHP Group (BHP), which climbed 8.3% and 2.2% respectively. They were followed by cruise line operator Carnival (CUK) and biopharmaceutical company Amarin (AMRN), which increased 2% and 1% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical companies Verona Pharma (VRNA) and Mereo BioPharma (MREO), which fell 10.8% and 8.8% respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and biotech firm Trinity Biotech (TRIB), which were down 2.8% and 0.8% respectively.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.